Azelis Group NV/€AZE

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Azelis Group NV

Azelis Group NV operates within the specialty chemicals and food ingredients industry, focusing on the distribution of innovative chemical and food ingredients. The company serves various sectors, including personal care, food and health, animal nutrition, home care, and industrial applications. Established in 2001, Azelis is headquartered in Antwerp, Belgium, and has developed a strong global presence with operations in over 50 countries. Its strategic positioning benefits from a network of laboratories and technical centers, enabling tailored solutions and value-added services for customers. Azelis’s competitive strength lies in its ability to leverage deep local market insights while maintaining close relationships with key suppliers.

Ticker

€AZE

Primary listing

BSE

Employees

4,321

Azelis Group NV Metrics

BasicAdvanced
€2.7B
16.58
€0.69
0.54
€0.16
1.38%

Bulls say / Bears say

Strong free cash flow generation: In H1 2025, Azelis generated €151 million in free cash flow, a 10.8% year-on-year increase, showing solid cash conversion despite EBITDA headwinds (Euronext).
Resilient EMEA performance: EMEA revenue rose 6.7% to €979.1 million in H1 2025 (9.0% at constant currency), led by 4.8% organic growth and successful bolt-on acquisitions, underscoring the resilience of core European markets (Euronext).
Strategic acquisitions driving niche growth: Azelis completed the acquisitions of Solchem and S Amit Group in H1 2025, expanding its footprint in Spanish nutraceuticals and Indian specialty chemicals, further strengthening its growth platforms (Euronext).
Margin pressure due to business mix: Gross profit margin fell by 68 basis points in H1 2025 to 23.9%, as a greater proportion of revenue came from lower-margin Industrial Chemicals businesses (Euronext).
Net profit declined in H1: Net profit dropped 14.6% year-on-year to €85 million in H1 2025, due to lower operating profit and increased costs ahead of the growth phase (Euronext).
Limited organic growth amid FX headwinds: H1 revenue grew just 0.6%, with organic growth at only 1.2%, offset by a 2.7% foreign exchange translation headwind. This highlights currency risks and continued reliance on acquisitions (Euronext).
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €AZE

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs